Congress wants a single ALS patient to get a therapy never tested in humans. A family in Iowa believes the Food and Drug Administration will decide whether their only surviving daughter lives or dies, and they’ve been on a monthslong crusade to break through its bureaucracy. And they’re succeeding

Quick Read

Novartis AG is expected to begin selling Zolgensma, a possible cure for spinal muscular atrophy, after the FDA approves it this month. Novartis executives say Zolgensma’s ability to curb SMA—a muscle-wasting disease that often kills babies before age 2—explains the eye-popping price

Quick Read

Critics are concerned about the explosion in controversial stem cell procedures offered by clinics—and, increasingly, respected hospitals

Quick Read

“We’re Still Waiting”

February 4, 2019

As cystic fibrosis drugs deliver new hope, not everyone is being swept up by scientific progress

Quick Read

This briefing note from the Nuffield Council on Bioethics examines the ethical issues that can arise when patients and doctors wish to use experimental treatments

Quick Read

Nearly 40 percent of Americans incorrectly believe that alternative medicine can cure cancer, a new study out Tuesday finds. “People feel like these types of therapies align with their personal and philosophical beliefs about managing their health,'”said one expert

Quick Read

Desperate & Duped?

October 24, 2018

GoFundMe means big bucks for dubious care. People seeking dubious, potentially harmful treatment for cancer and other ailments raised nearly $7 million over two years from crowdfunding sites, a study found

Quick Read

The Last Resort

March 27, 2018

Private clinics in Germany sell cancer patients hope — and mixed results — at exorbitant prices. Some, like the Hallwang Clinic, cater primarily to foreigners

Quick Read